Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SphinCS is a specialized contract research organization (CRO) based in Germany that focuses on the analysis of sphingolipids and other bioactive lipids. Utilizing advanced liquid chromatography-tandem mass spectrometry (LC-MS/MS) techniques, the company provides precise quantification of lipid biomarkers for clinical trials and preclinical research. SphinCS supports drug development programs by offering insights into lipid signaling pathways involved in inflammation, pain, and metabolic disorders. Their services include method development, validation, and high-throughput sample analysis to facilitate the discovery of novel therapeutic targets. The company is particularly known for its expertise in monitoring therapeutic interventions that target the sphingolipid rheostat. By bridging the gap between basic lipid research and clinical application, SphinCS serves as a key partner for pharmaceutical companies and academic institutions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SphinCS.